Urinary Symptoms in Multiple Sclerosis: Relation with Urodynamic Findings and Impact on Patient's Quality of Life

Basit Öğe Kaydı
dc.contributor.authorSungur, Ulas
dc.contributor.authorAkkoc, Yesim
dc.contributor.authorYuceyar, Nur
dc.contributor.authorEkmekci, Ozgul
dc.date.accessioned2019-10-27T09:47:42Z
dc.date.available2019-10-27T09:47:42Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: We aimed to investigate the correlations of urinary symptoms with urodynamic findings in patients with multiple sclerosis (MS) and their effects on quality of life. Methods: Nineteen MS patients with urinary symptoms were included. The data were obtained from files or with face-to-face interviews. Symptom types of patients were categorized as irritative, obstructive, and mixed. The Incontinence Quality of Life Scale, the King's Quality of Life Questionnaire (KQL) and the International Consultation on Incontinence Modular Questionnaire-Short Form were used to determine the effect of urinary symptoms on quality of life. The Extended Disability Status Scale (EDSS) was used to assess disability. All patients underwent urodynamic examination. Results: Of the 478 patients, 34.5% had visited a psychiatrist once in their lifetime, 13.6% were diagnosed with depression, and 13.8% did not know the diagnosis of mental disease; 32.2% were suggested medication by their doctor, 16.7% did not know the name of this medication, and 13.2% stated that the suggested drug was antidepressant. Moreover, 24.9% of the patients were known to use antidepressant at least once in their lifetime, and 16.3% were still using antidepressants. Among patients using antidepressants, 32% continued using this drug upon doctor's recommendation and 13.6% continued with the diagnosis of depression. Conclusion: The urinary symptoms significantly affect the quality of life in MS patients. Since symptoms do not always correlate with the underlying pathology, it is more appropriate to give the treatment based on the bladder type in urodynamic testing.en_US
dc.identifier.doi10.33808/clinexphealthsci.564239
dc.identifier.endpage150en_US
dc.identifier.issn2459-1459
dc.identifier.issn2459-1459en_US
dc.identifier.issue2en_US
dc.identifier.startpage143en_US
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.564239
dc.identifier.urihttps://hdl.handle.net/11454/29435
dc.identifier.volume9en_US
dc.identifier.wosWOS:000473218600009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherMarmara Univ, Inst Health Sciencesen_US
dc.relation.ispartofClinical and Experimental Health Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple sclerosisen_US
dc.subjectneurogenic bladder dysfunctionen_US
dc.subjectquality of lifeen_US
dc.subjecturodynamic findingsen_US
dc.titleUrinary Symptoms in Multiple Sclerosis: Relation with Urodynamic Findings and Impact on Patient's Quality of Lifeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu